Bright Minds Biosciences ...

NASDAQ: DRUG · Real-Time Price · USD
41.80
-0.74 (-1.74%)
At close: Aug 15, 2025, 3:59 PM
42.13
0.78%
After-hours: Aug 15, 2025, 07:25 PM EDT

Bright Minds Biosciences Cash Flow Statement

Financials in CAD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-3.44M -1.07M -2.8M -3.56M -5.24M -6.72M -7.37M -8.81M -10.01M -12.44M -14.96M -14.87M -15.75M -12.76M -8.65M -6.19M -2.68M -1.2M
Depreciation & Amortization
81.15K 76.78K 73.36K 72.45K 72.45K 72.45K 72.45K 60.38K 42.26K 24.15K 6.04K n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
1.19M 797.21K 839.77K 1.03M 1.08M 886.94K 1.15M 781.55K 837.39K 1.1M 875.06K 1.22M 1.19M 905.13K 880.62K 665.35K 404.55K 397.71K
Other Working Capital
-133.89K -133.59K 556.08K 140.64K 42.38K 472.83K -1.05M 210.19K -151.44K -39.19K 771.94K 119.95K 781.67K 387.67K 510.62K 225.26K 176.86K -60.08
Other Non-Cash Items
-1.65M -898.74K 727.6K 743.76K 786.7K 2.01M 2.02M 1.97M 1.97M -25.11K -223.54K -332.4K -43.43K -46.62K 144.75K 297.16K 3.96K 134.73
Deferred Income Tax
n/a n/a 42.3K 205.73K 75.26K 75.26K 32.97K -136.51K -6.04K -6.04K -6.04K n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-317.24K -658.6K 39.81K -308.93K -477.5K 487.07K -930.33K 170.95K -8.4K 51.23K 726.31K 133.5K 641.52K 237.98K 306.08K 83.65K 126.4K -35.36K
Operating Cash Flow
-4.14M -2.52M -1.85M -2.58M -4.48M -3.19M -5.03M -5.96M -7.17M -11.3M -13.59M -13.85M -13.96M -11.66M -7.32M -5.14M -2.15M -840.03K
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 22.88 n/a n/a n/a -22.88
Investing Cash Flow
n/a n/a n/a n/a n/a -11.19M -11.19M -11.19M -11.19M n/a n/a n/a n/a 22.88 n/a n/a n/a -22.88
Debt Repayment
-94.24K -91.56K -89.73K -87.52K -87.05K -86.58K -86.11K -39.63K -18.14K 3.35K 24.84K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -9.7 -9.7 -9.7 -9.7 n/a -10 -10
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.69M 3.44M 302.00 n/a n/a n/a 1.06M 2.06M 2.07M 2.08M 1.14M 122.23K -435.32K -1.63M -1.73M -1.72M -1.17M 22.88K
Financial Cash Flow
52.22M 51.97M 810.57K 812.48K 812.95K 813.42K 2.19M 7.28M 7.31M 7.33M 5.2M 122.23K -435.32K 24.3M 26.06M 26.99M 27.53M 2.88M
Net Cash Flow
49.75M 51.14M -1.03M -1.94M -3.74M -13.64M -14.07M -9.7M -10.99M -3.91M -8.13M -13.37M -13.98M 13.05M 18.96M 21.92M 25.38M 2.04M
Free Cash Flow
-4.14M -2.52M -1.85M -2.58M -4.48M -3.19M -5.03M -5.96M -7.17M -11.3M -13.59M -13.85M -13.96M -11.66M -7.32M -5.14M -2.15M -840.03K